Nicotinamide May Lower Risk of Most Common Types of Skin Cancer
A University of Sydney-published research unveiled that nicotinamide, a form of vitamin B3, can help bring a decline in risk of the most common types of skin cancer in people who are more vulnerable to acquire the disease.
As per the research, the vitamin reduced the incidents of new, non-melanoma skin cancers in people by 23%. These people were the ones who already had at least two of the cancer in the past five years.
An experiment was carried out in which the vitamin was compared with a placebo. The vitamin taken in the form of pill twice on daily basis was compared with a placebo. The American Society of Clinical Oncology said that the findings are welcoming.
It may reduce some health burden and cost of skin cancer, which is said to be the most common form of the disease in fair-skinned people. Dr Peter Paul Yu, ASCO president and director of cancer research at Palo Alto Medical Foundation, said that it is quite a cost effective vitamin. People can start having it if there is a need for the same.
The researchers said that main reason behind non-melanoma skin cancer is to get exposed to ultraviolet radiations from the sun. These radiations will damage cellular DNA and suppresses the skin’s immune system ability to get away with abnormal cells.
Study’s lead author Diona Damian, professor of dermatology at the University of Sydney, said that on the basis of 386-patient study, it has been found that nicotinamide reduced the risk for both basal cell and squamous cell carcinomas.
The preventive effect started to be seen as early as three month after treatment started, but the effect stopped soon after the patients did not take the pills. It indicates that there is a need to take the pill on regular basis to see the effect.
The overall ‘asthma epidemic’ among children has...Read More
People in huge numbers gathered in the Mount Lofty...Read More
As New Year is approaching, people have already...Read More
Alzheimer’s disease, the commonest cause of...Read More
Cases of opioid abuse have been increasing and...Read More
In an announcement made on December 22, cable giant...Read More